Nkarta, Inc. (NKTX) Financials
NKTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 405.9 million | 109.0 million |
2023-06-30 | 429.0 million | 111.1 million |
2023-03-31 | 458.2 million | 111.5 million |
2022-12-31 | 472.9 million | 100.7 million |
NKTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -26.5 million | 4.3 million |
2023-06-30 | -32.1 million | 4.7 million |
2023-03-31 | -25.6 million | 4.7 million |
2022-12-31 | -42.4 million | 4.5 million |
NKTX Net Income
No data available :(
NKTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 275.6 million | - | 89.5 million |
2023-06-30 | 280.8 million | - | 90.5 million |
2023-03-31 | 323.3 million | - | 91.3 million |
2022-12-31 | 354.9 million | - | 82.9 million |
NKTX Shares Outstanding
NKTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 6.2 million | 22.2 million | 7.1 million | - |
2023-06-30 | 10.3 million | 25.1 million | 11.7 million | - |
2023-03-31 | 4.8 million | 26.1 million | 8.2 million | - |
2022-12-31 | 35.0 million | 26.8 million | 8.1 million | - |
NKTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 2.5 million |
2023-06-30 | - | 1.4 million |
2023-03-31 | - | 1.3 million |
2022-12-31 | - | 1.4 million |
NKTX
Price: $7.10
52 week price:
Earnings Per Share: -2.40 USD
P/E Ratio: -4.16
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 296100
Market Capitalization: 615.5 million